Tag:
Genmab
Latest Headlines
Latest Headlines
Lonza steps up for GSK and Genmab
Arzerra, the recently approved monoclonal antibody treatment for leukemia from GlaxoSmithKline and Genmab, will be manufactured by Lonza. The Swiss-based contract manufacturer performed process
Genmab to shutter U.S. plant, cut 300 jobs
Denmark-based Genmab plans to cut some 300 jobs and sell off a U.S. manufacturing plant as it downgrades its expectations for 2009 sales for the second time; "cost pressures" in the pharma industry
